Cladribine, Low-Dose Cytarabine (LDAC), and Venetoclax (VEN) in Older/Unfit Acute Myeloid Leukemia (AML) Patients: A Single-Institution Experience

被引：0

作者：

Yohannan, Binoy ^{[1
]}

Khan, Hina ^{[1
]}

Cervoni-Curet, Frances ^{[1
]}

Rios, Adan ^{[1
]}

机构：

[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

AML; cladribine; low-dose cytarabine; older/unfit AML;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-100

引用

页码：S267 / S267

页数：1

共 50 条

[31] LOW-DOSE CYTARABINE IN ACUTE MYELOID-LEUKEMIA
MANOHARAN, A
LEYDEN, MJ
SULLIVAN, J
MEDICAL JOURNAL OF AUSTRALIA, 1984, 141 (10) : 643 - 646
[32] Cladribine with Low Dose Cytarabine and Venetoclax Alternated with Azacytidine and Venetoclax for Acute Myeloid Leukemia: Prognostic Analysis of a Phase 2 Clinical Trial
Bataller, Alex
Bazinet, Alexandre
Borthakur, Gautam
Short, Nicholas J.
Jabbour, Elias
Takahashi, Koichi
Daver, Naval
Issa, Ghayas C.
DiNardo, Courtney D.
Pemmaraju, Naveen
Jain, Nitin
Montalban-Bravo, Guillermo
Wierda, William G.
Garcia-Manero, Guillermo
Ravandi, Farhad
Kantarjian, Hagop M.
Kadia, Tapan M.
BLOOD, 2023, 142
[33] Arsenic Trioxide and Low-dose Cytarabine in Older Patients With Untreated Acute Myeloid Leukemia, Excluding Acute Promyelocytic Leukemia
Roboz, Gail J.
Ritchie, Ellen K.
Curcio, Tania
Provenzano, Juliette
Carlin, Rebecca
Samuel, Michael
Wittenberg, Beth
Mazumdar, Madhu
Christos, Paul J.
Mathew, Susan
Allen-Bard, Sandra
Feldman, Eric J.
CANCER, 2008, 113 (09) : 2504 - 2511
[34] Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients
Miklos, Egyed
Oliver, Toth Peter
Adam, Kellner
Eva, Karadi
Balazs, Kollar
Eszter, Kovacs
Anett, Pavlovics
Viktoria, Gyori-Korom
Jozsef, Herczeg
Peter, Rajnics
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (02) : 183 - 189
[35] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
Ferrara, Felicetto
BLOOD CANCER JOURNAL, 2020, 10 (01)
[36] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
Felicetto Ferrara
Blood Cancer Journal, 10
[37] Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia:a single-institution experience
于文静
ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (02) : 120 - 121
[38] Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review
Amador-Medina, Lauro Fabian
Crespo-Solis, Erick
Turrubiates-Herna, Francisco Javier
Santibanez-Bedolla, Karla Edith
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S322 - S331
[39] Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
Budziszewska, Bozena Katarzyna
Salomon-Perzynski, Aleksander
Pruszczyk, Katarzyna
Barankiewicz, Joanna
Pluta, Agnieszka
Helbig, Grzegorz
Janowska, Anna
Kuydowicz, Marta
Bolkun, Lukasz
Piszcz, Jaroslaw
Patkowska, Elzbieta
Watek, Marzena
Malecki, Piotr
Kosciolek-Zgodka, Sylwia
Cichocka, Edyta
Charlinski, Grzegorz
Irga-Staniukiewicz, Anna
Zaucha, Jan Maciej
Piekarska, Agnieszka
Gromek, Tomasz
Hus, Marek
Wojcik, Karol
Razny, Malgorzata
Sedzimirska, Mariola
Pula, Bartosz
Giebel, Sebastian
Grosicki, Sebastian
Wierzbowska, Agnieszka
Lech-Maranda, Ewa
CANCERS, 2021, 13 (16)
[40] Frontline Therapy for Older Patients (pts) with Acute Myeloid Leukemia (AML): Clofarabine Plus Low-Dose Cytarabine Induction Followed by Prolonged Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with Decitabine
Faderl, Stefan
Ravandi, Farhad
Garcia-Manero, Guillermo
Huang, Xuelin
Jabbour, Elias
Kadia, Tapan
Ferrajoli, Alessandra
Estrov, Zeev
Feliu, Jennie
Schroeder, Heather
Kwari, Monica
Kantarjian, Hagop
BLOOD, 2010, 116 (21) : 152 - 152

← 1 2 3 4 5 →